PRACTICAL ONCOLOGY JOURNAL ›› 2012, Vol. 26 ›› Issue (4): 343-347.doi: 10.3969/j.issn.1002-3070.2012.04.013

Previous Articles     Next Articles

The clinical diagnostic and therapeutic situation of cancer-related neuropathic pain in 165 patients with pain

SHEN Qian1,YIN Yuping2,YU Shiying1   

  1. 1.Cancer center of Tongji Hospital Affiliated to Huazhong University of Science and Technology,Wuhan 430030;
    2.Union Hospital Affiliated to Huazhong University of Science and Technology;
    3.Cancer Center of Tongji Hospital Affiliated to Huazhong University of Science and Technology
  • Received:2012-05-10 Online:2012-08-28 Published:2014-12-03

PDF (PC)

91

Abstract: Objective To investigate the clinical diagnostic and therapeutic situation of cancer related neuropathic pain in the cancer center of Tongji hospital;to promote the standard clinical diagnosis and treatment of intractable cancer pain.Method This is a non-intervening,open and observational clinical research.165 patients screening out from a total of 206 patients with cancer pain,referred to the cancer center of Tongji hospital,were evaluated and followed,using NRS,LANSS and IDPain.Results In 165 cancer pain patients,there were 103(62.42%)patients with cancer-related neuropathic pain.The incidence rate of cancer-related neuropathic pain in cancer pain patients was not related with age and gender.Patients with higher NRS were more likely to experience cancer-related neuropathic pain.In cancer-related neuropathic pain patients,there were 54(52.43%)patients using adjuvant analgesics.By those adjuvant analgesics,most patients were well tolerated,only few reported adverse reaction.Conclusion Cancer-related neuropathic pain has called“doctors′ attention” in recent years.Adjuvant analgesics play an important role in the management of cancer-related neuropathic pain.

CLC Number: